When Americord responded to the FDA’s request for an impact status, it learned that many cord blood banks were “severely impacted” by the storm, according to the FDA.
Past News ReleasesRSS
New York, NY (PRWEB) November 14, 2012
Americord Registry, headquartered in New York City, was one of the few cord blood banks able to remain fully operational throughout the entire duration of Hurricane Sandy. When Americord responded to the FDA’s request for an impact status, it learned that many cord blood banks were “severely impacted” by the storm, according to the FDA. After Sandy brought historic flooding to the Northeast region, the company’s staff pulled together to ensure that the cord blood of two newborn babies in Newark, New Jersey was safely collected at the hospital. With their medical courier navigating congested roadways, staff at headquarters relayed information from Twitter to guide the driver successfully to one of the few open gas stations in the area so he could make the pick-up.
“In the aftermath of Sandy, we remain very concerned about the local communities in New York and New Jersey,” said Americord CEO Martin Smithmyer, who participated in recovery efforts as a volunteer on Staten Island in the days following the storm. “Americord is dedicated to being a responsible corporate citizen of this great community. Americord is focused on providing the highest quality cord blood banking services at the best value available on the market, and we are committed to being there for parents, no matter when their baby arrives – even if that is in the middle of an unprecedented storm.”
Americord will be celebrating the ongoing recovery efforts along with New Yorkers on Monday November 19th at the Biggest Baby Shower Ever, an event hosted by Big City Moms at the Metropolitan Pavilion in New York City. Company representatives will be available to educate and inform attendees about cord blood banking.
About Americord Registry
Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry's website at http://www.cordadvantage.com for more information. You may also find Americord Registry on Facebook and follow the company on Twitter.